RC Shelton
Geciteerd door
Geciteerd door
Antidepressant drug effects and depression severity: a patient-level meta-analysis
JC Fournier, RJ DeRubeis, SD Hollon, S Dimidjian, JD Amsterdam, ...
Jama 303 (1), 47-53, 2010
Cognitive therapy vs medications in the treatment of moderate to severe depression
RJ DeRubeis, SD Hollon, JD Amsterdam, RC Shelton, PR Young, ...
Archives of general psychiatry 62 (4), 409-416, 2005
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression
SD Hollon, RJ DeRubeis, RC Shelton, JD Amsterdam, RM Salomon, ...
Archives of general psychiatry 62 (4), 417-422, 2005
A novel augmentation strategy for treating resistant major depression
RC Shelton, GD Tollefson, M Tohen, S Stahl, KS Gannon, TG Jacobs, ...
American Journal of Psychiatry 158 (1), 131-134, 2001
Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia.
MT Treadway, NA Bossaller, RC Shelton, DH Zald
Journal of abnormal psychology 121 (3), 553, 2012
Effectiveness of St John's wort in major depression: a randomized controlled trial
RC Shelton, MB Keller, A Gelenberg, DL Dunner, R Hirschfeld, ME Thase, ...
Jama 285 (15), 1978-1986, 2001
Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial
EJ Daly, JB Singh, M Fedgchin, K Cooper, P Lim, RC Shelton, ME Thase, ...
JAMA psychiatry 75 (2), 139-148, 2018
Functional biomarkers of depression: diagnosis, treatment, and pathophysiology
HD Schmidt, RC Shelton, RS Duman
Neuropsychopharmacology 36 (12), 2375-2394, 2011
Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression
RC Shelton, J Claiborne, M Sidoryk-Wegrzynowicz, R Reddy, M Aschner, ...
Molecular psychiatry 16 (7), 751-762, 2011
A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression
JB Singh, M Fedgchin, EJ Daly, P De Boer, K Cooper, P Lim, C Pinter, ...
American Journal of Psychiatry 173 (8), 816-826, 2016
Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind …
V Popova, EJ Daly, M Trivedi, K Cooper, R Lane, P Lim, C Mazzucco, ...
American Journal of Psychiatry 176 (6), 428-438, 2019
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study
AJ Rush, MH Trivedi, JW Stewart, AA Nierenberg, M Fava, BT Kurian, ...
American Journal of Psychiatry 168 (7), 689-701, 2011
Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.
JC Fournier, RJ DeRubeis, RC Shelton, SD Hollon, JD Amsterdam, ...
Journal of consulting and clinical psychology 77 (4), 775, 2009
Personality change during depression treatment: a placebo-controlled trial
TZ Tang, RJ DeRubeis, SD Hollon, J Amsterdam, R Shelton, B Schalet
Archives of general psychiatry 66 (12), 1322-1330, 2009
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major …
GI Papakostas, ME Thase, M Fava, JC Nelson, RC Shelton
Biological psychiatry 62 (11), 1217-1227, 2007
Cognitive therapy and pharmacotherapy for depression.
SD Hollon, RC Shelton, PT Loosen
Journal of consulting and clinical psychology 59 (1), 88, 1991
Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial
EJ Daly, MH Trivedi, A Janik, H Li, Y Zhang, X Li, R Lane, P Lim, AR Duca, ...
JAMA psychiatry 76 (9), 893-903, 2019
Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features
AJ Rush, M Zimmerman, SR Wisniewski, M Fava, SD Hollon, D Warden, ...
Journal of affective disorders 87 (1), 43-55, 2005
l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials
GI Papakostas, RC Shelton, JM Zajecka, B Etemad, K Rickels, A Clain, ...
American Journal of Psychiatry 169 (12), 1267-1274, 2012
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.
GI Papakostas, RC Shelton, J Smith, M Fava
Journal of Clinical Psychiatry 68 (6), 826-831, 2007
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20